Clinical, radiographic, and patient-centered outcomes after use of enamel matrix proteins for the treatment of intrabony defects in patients with aggressive periodontitis: A 12-month multicenter clinical trial.

Ana Lívia Fileto MazzonettoRenato Correa Viana Casarin Mauro Pedrine SantamariaNaira Maria Rebelatto Bechara AndereCássia Fernandes AraújoRafaela Videira Clima da SilvaJavier Eduardo Vivanco PurisacaEnilson Antonio SallumAntonio Wilson Sallum

Published in: Journal of periodontology (2020)

EMD therapy of intrabony defects promotes additional benefits in AgP patients, presenting a similar regeneration rate compared to CP patients, and has proven to be a viable therapy for the treatment of individuals with AgP.

Keyphrases

end stage renal disease
clinical trial
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
randomized controlled trial
mesenchymal stem cells
patient reported outcomes
cross sectional
phase ii
replacement therapy
open label
smoking cessation